Seoul National University Hospital: Breast Neoplasms trials

The registry lists 46 Breast Neoplasms studies with Seoul National University Hospital as lead sponsor. 12 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 11Phase 3 5Phase 4 1No phase 29(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in KoreaRecruitingNCT06928818
• No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant ChemotherapyRecruitingNCT06704945Phase 3
• Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer SurgeryNot yet recruitingNCT06575049
• Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 InhibitorRecruitingNCT05536128Phase 2
• Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)RecruitingNCT05505357Not applicable
• Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study)RecruitingNCT05460975
• The Postoperative Radiotherapy in N1 Breast Cancer PatientsRecruitingNCT05440149Phase 3
• Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast CancerRecruitingNCT05307757
• Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant DeficiencyRecruitingNCT04892693Phase 2
• Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast CancerRecruitingNCT04656639
• Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast CancerEnrolling by invitationNCT04098640Not applicable
• Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)RecruitingNCT03664895Phase 3
• Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.CompletedNCT03273426Not applicableResults posted
• PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast CancerCompletedNCT01190566Results posted
• Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer SurvivorsCompletedNCT00981305Phase 3Results posted
• TME Alteration in HER2 Positive Breast CancerActive, not recruitingNCT06533670
• Locoregional Recurrence After Neoadjuvant Versus Adjuvant ChemotherapyCompletedNCT06299930
• Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic SensorCompletedNCT06255808
• Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer PatientsActive, not recruitingNCT04997941Phase 2
• Shared Decision Making in Surveillance for Distant Metastasis in Breast CancerActive, not recruitingNCT04862078Not applicable
• Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast CancerActive, not recruitingNCT04689529Not applicable
• Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast CancerSuspendedNCT04619186
• Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast CancerTerminatedNCT04549584
• Chemotherapy-induced Circadian Rhythm DisruptionStatus unknownNCT04364347
• No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonographyActive, not recruitingNCT04303715Not applicable
• Nivolumab and Eribulin in HER2 Negative Metastatic Breast CancerStatus unknownNCT04061863Phase 1/2
• PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS RateActive, not recruitingNCT03900637Phase 2
• Breast Cancer Screening With Diffusion-weighted MRI in Women at High Risk for Breast CancerStatus unknownNCT03835897
• Circulating Osteocalcin-positive Cells in Breast Cancer Bone MetastasisStatus unknownNCT03814811
• Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast CancerActive, not recruitingNCT03594396Phase 1/2
• Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation TestingStatus unknownNCT03475979
• PemVin vs Vin in Previously Treated Metastatic Breast CancerCompletedNCT03242616Phase 2
• Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking TamoxifenTerminatedNCT02819921Phase 4
• Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing PositivelyCompletedNCT02650661Not applicable
• Exploring Biological Linkage Between Circadian Disruption and Cancer ProgressionCompletedNCT02011815
• Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense BreastsCompletedNCT01910103
• The Effects of Circadian Gene on Sleep and Associated Symptoms in Breast Cancer Patients Under ChemotherapyCompletedNCT01887925
• Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated BreastsWithdrawnNCT01801878Not applicable
• Breast Density Change Predicting Response to Adjuvant Aromatase InhibitorActive, not recruitingNCT01765049
• Clinical Trial to Evaluate the Safety and Efficacy of Breast ImplantStatus unknownNCT01711710Not applicable
• Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast CancerCompletedNCT01589367Phase 2
• PET in Breast Cancer Receiving Neoadjuvant ChemotherapyCompletedNCT01396655Phase 2
• Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving TherapyCompletedNCT01257152
• Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer PatientsCompletedNCT00909506Phase 2
• Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer PatientsCompletedNCT00607295Phase 3
• Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast CancerCompletedNCT00527930Phase 2